Events 15 June 2021

18 June 2021 | Virtual

Announcements 15 June 2021

Houston, TX, and Singapore, June 14, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies...

Announcements 09 June 2021

-- Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience’s lead program, HMBD-001 Houston, TX, and Singapore,...

Announcements 31 May 2021

- HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development- HMBD-002 is anticipated to enter a Phase 1...

Announcements 27 May 2021

Pharma Intelligence’s Insights speaks to Hummingbird CEO Piers Ingram following the Singapore-based company’s Series C financing round.

Announcements 27 May 2021

Hummingbird discusses our HER3 program and how we are tackling the challenges of therapeutics development.

Announcements 27 May 2021

Hummingbird discusses why cutting-edge digital tools and data-rich computational approaches play a powerful role in the development of precision biotherapeutics.

Announcements 18 May 2021

-- Investment round led by Novo Holdings, joined by a syndicate of international biotechinvestors-- Proceeds will support advancement of Hummingbird’s...